Copyright
©The Author(s) 2020.
World J Gastroenterol. Jun 28, 2020; 26(24): 3472-3483
Published online Jun 28, 2020. doi: 10.3748/wjg.v26.i24.3472
Published online Jun 28, 2020. doi: 10.3748/wjg.v26.i24.3472
Table 2 Results of liver function tests for patients in the two groups
| Group and time point | TBil (μmol/L) | DBil (μmol/L) | ALT (U/L) | AST (U/L) |
| TIPS group | ||||
| Before treatment (n = 37) | 53.30 (39.80) | 32.40 (32.60) | 45.00 (69.00) | 65.00 (48.00) |
| 1 wk after treatment (n = 36) | 60.20 (70.60) | 44.85 (49.43) | 40.50 (53.00) | 59.00 (65.00) |
| 2 wk after treatment (n = 35) | 56.40 (30.40) | 35.20 (28.40) | 36.00 (26.00) | 47.00 (17.00)a |
| 1 mo after treatment (n = 35) | 47.20 (13.70)c | 29.20 (14.10)c | 26.00 (20.00)ace | 40.00 (16.00)ac |
| 3 mo after treatment (n = 35) | 44.20 (9.70)c | 27.40 (13.10)c | 31.00 (11.00) | 41.00 (12.00)ac |
| P value | < 0.05 | < 0.05 | < 0.05 | < 0.05 |
| Conservative treatment group | ||||
| Before treatment (n = 17) | 53.60 (45.00) | 37.40 (47.00) | 55.00 (86.0) | 62.00 (89.00) |
| 1 wk after treatment (n = 17) | 67.80 (41.60) | 43.60 (35.95) | 56.00 (99.00) | 67.00 (109.00) |
| 2 wk after treatment (n = 16) | 52.25 (71.30) | 37.60 (60.30) | 44.00 (42.00) | 53.50 (44.00) |
| 1 mo after treatment (n = 16) | 44.40 (39.24) | 31.20 (31.80) | 34.50 (44.00) | 41.50 (50.00) |
| 3 mo after treatment (n = 12) | 38.15 (37.95) | 26.00 (35.80) | 25.00 (55.00) | 39.00 (64.00) |
| P value | > 0.05 | > 0.05 | > 0.05 | > 0.05 |
- Citation: Zhou CZ, Wang RF, Lv WF, Fu YQ, Cheng DL, Zhu YJ, Hou CL, Ye XJ. Transjugular intrahepatic portosystemic shunt for pyrrolizidine alkaloid-related hepatic sinusoidal obstruction syndrome. World J Gastroenterol 2020; 26(24): 3472-3483
- URL: https://www.wjgnet.com/1007-9327/full/v26/i24/3472.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i24.3472